|
|
???tair.name??? >
???browser.page.title.author???
|
"tanwandee tanwandee t"???jsp.browse.items-by-author.description???
Showing items 1-4 of 4 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2019 |
Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infection
|
Wei, L.;Kumada, H.;Perumalswami, Perumalswami P.V.;Tanwandee, Tanwandee T.;Cheng, W.;Heo, J.;Cheng, P.-N.;Hwang, P.;Mu, S.M.;Zhao, X.M.;Asante-Appiah, E.;Caro, L.;Hanna, G.J.;Robertson, M.N.;Haber, B.A.;Talwani, R. |
| 國立成功大學 |
2019 |
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
|
Qin, S.;Chan, S.L.;Sukeepaisarnjaroen, W.;Han, G.;Choo, S.P.;Sriuranpong, V.;Pan, H.;Yau, T.;Guo, Y.;Chen, M.;Ren, Z.;Xu, J.;Yen, C.-J.;Lin, Z.-Z.;Manenti, L.;Gu, Y.;Sun, Y.;Tiedt, R.;Hao, L.;Song, W.;Tanwandee, Tanwandee T. |
| 國立成功大學 |
2019 |
Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia–Pacific region and Russia: Final results from the randomized C-CORAL study
|
Wei, L.;Jia, Jia J.D.;Wang, F.S.;Niu, J.Q.;Zhao, X.M.;Mu, S.;Liang, Liang L.W.;Wang, Z.;Hwang, P.;Robertson, M.N.;Ingravallo, P.;Asante-Appiah, E.;Wei, B.;Evans, B.;Hanna, G.J.;Talwani, R.;Duan, Z.P.;Zhdanov, K.;Cheng, P.-N.;Tanwandee, Tanwandee T.;Nguyen, V.K.;Heo, J.;Isakov, V.;George, J.;Investigators, on behalf of the C-CORAL |
| 國立成功大學 |
2018 |
Elbasvir/grazoprevir in Asia-Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection
|
George, J.;Burnevich, E.;Sheen, I.-S.;Heo, J.;Kinh, N.V.;Tanwandee, Tanwandee T.;Cheng, P.-N.;Kim, D.Y.;Tak, W.Y.;Kizhlo, S.;Zhdanov, K.;Isakov, V.;Liang, Liang L.;Lindore, P.;Ginanni, J.;Nguyen, B.-Y.;Wahl, J.;Barr, E.;Robertson, M.;Ingravallo, P.;Talwani, R.;Investigators, on behalf of the C-CORAL Study |
Showing items 1-4 of 4 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
